Cargando…
Curative treatment for stage IIIC2 cervical cancer: what to expect?
BACKGROUND: Since the GOG125 study, treating radically patients with positive para-aortic lymph nodes has been a valid approach. Nevertheless, literature lacks data on how to better treat these patients since they are usually excluded from trials. In this study, we aimed to report the outcomes of pa...
Autores principales: | Mauro, Geovanne Pedro, de Aquino Calheiros, Vinicius, Vonsowski, Matheus Sorgi, Avelar, Talita, de Andrade Carvalho, Heloisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547400/ https://www.ncbi.nlm.nih.gov/pubmed/37795398 http://dx.doi.org/10.5603/RPOR.a2023.0036 |
Ejemplares similares
-
History of radiotherapy in the treatment of uterine cervix cancer: an overview
por: Carvalho, Heloisa de Andrade, et al.
Publicado: (2023) -
Hypofractionated radiotherapy in breast cancer: a 10-year single institution experience
por: Najas, Gabriel Faria, et al.
Publicado: (2021) -
Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer
por: Chang, Hong, et al.
Publicado: (2023) -
Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery
por: Fan, Xiang, et al.
Publicado: (2023) -
Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
por: Ye, Yanna, et al.
Publicado: (2023)